Takeda eyes emerging markets asset sale to trim its debt; re...

AZ sells US, EU and Latin America rights to gout drug

AZ focused on sales target set by CEO Pascal Soriot.

NICE and Highly Specialised Technologies: three years on

Leela Barham examines the process for the appraisal of Highly Specialised Technologies.

The UK pharma market – Accelerating Access or still stuck in...

Hundreds of novel medicines are expected to gain approval between 2016 and 2020 but will the NHS make the most of the best new drugs, or limit access and uptake as in previous years?

Caribou gains $30m funding for CRISPR-Cas platform

Genetic engineering specialist Caribou Biosciences has secured $30 million in a series B funding round.

Livongo raises funds for digital health platform

US health insurance giant Humana has invested in digital health company Livongo to close off the start-up's series C financing round.